๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for DM

Multidisciplinary Dissection of Renal and Metabolic Effects of Glyfozines on Elderly Patients: From Molecular Aspects to Clinical Indications NCT07119424n/a1 site๐Ÿ“ Milan Chiara Lanzani Severity Factors of Dermatomyositis in the Caribbean Population - DM-ANTILLES NCT07265999n/a1 site๐Ÿ“ Pointe-ร -Pitre Centre Hospitalier Universitaire de la Guadeloupe Improving Diabetes Care With Strategies For Addressing Health-Related Social Needs and Community Partnerships NCT07043426NA1 site๐Ÿ“ Boston Boston Medical Center ยท Tests: THRIVE-DM, Standard of care Community Health Workers Led Integrated Management of Hypertension and Diabetes in Nepal NCT07432126NA1 site๐Ÿ“ Kavre Kathmandu University School of Medical Sciences ยท Tests: Integrated management of hypertension and diabetes using group care approach Technology-Enabled Collaborative Care for Diabetes and Mental Health NCT07181863NA2 sites๐Ÿ“ Hamilton๐Ÿ“ Toronto McMaster University ยท Tests: Health coaching, Educational emails Safety and Efficacy of ULSC on Disease Severity and Steroid Tapering in Participants With Dermatomyositis/ Polymyositis (DM/PM), Also Known as Idiopathic Inflammatory Myopathy (IIM) NCT07160205Phase 2, Phase 32 sites๐Ÿ“ Gainesville๐Ÿ“ Miami Restem, LLC. ยท Tests: ULSC (1.5 x 10^8 cells/dose), Placebo (no cells) Evaluating Glucose Control Using a Next-Generation AID Algorithm in Individuals With T1D NCT07593625NA1 site๐Ÿ“ Christchurch Insulet Corporation ยท Tests: Omnipod M System, Omnipod S Role of Alpha-to-beta Cell Communication to Adapt Insulin Secretion to Insulin Resistance. NCT07224334Phase 11 site๐Ÿ“ Durham David D'Alessio, M.D. ยท Tests: Exendin-9 is a 30 amino acid peptide that is an established competitive antagonist of the GLP-1 receptor. Subjects willโ€ฆ Integrating New Skills Into Diabetes Education With CGM NCT07463209NA1 site๐Ÿ“ Chapel Hill University of North Carolina, Chapel Hill ยท Tests: Three-stage CGM integration program, One-time clinic-based CGM training, Self-directed CGM training Cohort of Mexican Children With Diabetes Mellitus (CMC-DM) NCT02722655n/a1 site๐Ÿ“ Leรณn Hospital Regional de Alta Especialidad del Bajio Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2) NCT06906640NA7 sites๐Ÿ“ Birmingham๐Ÿ“ St. Petersburg๐Ÿ“ Ann Arbor Duke University ยท Tests: (IRIS-CKD Management Program): Education, (IRIS-CKD Management Program): GDMT Development of Quantitative Muscle Imaging as a Biomarker of Disease Endpoints in Myotonic Dystrophy NCT07362875n/a1 site๐Ÿ“ Winston-Salem Wake Forest University Health Sciences RCT Glargine vs NPH for Treatment of DM in Pregnancy NCT06619301Phase 31 site๐Ÿ“ Maywood Loyola University ยท Tests: Insulin glargine, insulin NPH Community-Based Chronic Disease Care in Rural Lesotho NCT05596773n/a2 sites๐Ÿ“ Maseru๐Ÿ“ Basel University Hospital, Basel, Switzerland Impact of the New Generation Anti-diabetic Drugs on Diabetic Retinopathy NCT07351786n/a1 site๐Ÿ“ Alexandria Sara A Belal Validation of Hemoglobin A1c in Patients With Inflammatory Arthritis Treated With Sulfasalazine NCT07416656n/a1 site๐Ÿ“ Silkeborg Klavs Wรผrgler Hansen Jockey Club Precision Prevention Programme on Young Onset Diabetes NCT06693934NA1 site๐Ÿ“ Hong Kong Juliana CN Chan ยท Tests: Risk assessment with biogenetic and clinical test to predict diabetes risk, Oral glucose tolerance test (OGTT) and cardโ€ฆ Evaluating the Efficacy of Pulsating Electromagnetic Field Therapy by CRAD ULCER X-01 for Diabetic Foot Ulcers NCT07465640NA1 site๐Ÿ“ Kuala Lumpur National Defence University of Malaysia ยท Tests: Pulsating electromagnetic field Remote Assessments and Genetic Determinants of Congenital and Childhood Myotonic Dystrophy NCT07630389n/a1 site๐Ÿ“ Rochester University of Rochester The NTU JO-SMART Study NCT07317310NA2 sites๐Ÿ“ Taipei๐Ÿ“ Yunlin National Taiwan University Hospital ยท Tests: NTU-JO Smart Program BCMA-CD19 cCAR-T for the Treatment of Refractory Inflammatory Myopathy NCT07715136Phase 11 site๐Ÿ“ Chengdu iCell Gene Therapeutics ยท Tests: ICG318, BCMA-CD19-IL-15/IL-15 sushi Compound CAR-T Joint Patient and Caregiver Intervention for Older African Americans With Type 2 Diabetes NCT06279637NA1 site๐Ÿ“ Milwaukee Medical College of Wisconsin ยท Tests: Joint Home-DM-BAT Intervention, Usual Care Changes in Person-reported Outcomes and Behavior Using the Accu-Chek SmartGuide CGM and Predict App NCT07814508NA1 site๐Ÿ“ Bad Mergentheim FIDAM RDC ยท Tests: SmartGuide CGM with Predictive Features Health for Hungary (H4H) - Longitudinal Collection of Blood Samples and Corresponding Data NCT07743021n/a33 sites๐Ÿ“ Balatonfรผred๐Ÿ“ Bรฉkรฉscsaba๐Ÿ“ Budapest Center for Molecular Fingerprinting Research Nonprofit LLC Cardiovascular and Renal Endpoints With Flozins - an Observational Prospective Study in CKD HFpEF Patients NCT07237451n/a1 site๐Ÿ“ Iaศ™i Grigore T. Popa University of Medicine and Pharmacy ยท Tests: Arterial stiffness, Echocardiography, Biomarkers determination, NMR metabolomics and uremic toxins mapping DM Treatment to Evaluate the Efficacy and Safety of Dapagliflozin or Pioglitazone in Patients with Type 2 Diabetes NCT06875193Phase 41 site๐Ÿ“ Seoul Dong Wha Pharmaceutical Co. Ltd. ยท Tests: DW6012(Dasidiem tab. 10/100mg) Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Registry NCT00082108n/a1 site๐Ÿ“ Rochester University of Rochester Post-Market Clinical Investigation Plan - Collagen Dura Membranes (DM & DMO) NCT06822920n/a1 site๐Ÿ“ Milwaukee Collagen Matrix A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)] NCT05895786Phase 3138 sites๐Ÿ“ Glendale๐Ÿ“ Phoenix๐Ÿ“ Phoenix Pfizer ยท Tests: PF-06823859, Placebo NT-ProBNP-based Heart Failure Screening and Prevention Trial in Patients With Type 2 Diabetes: STRONG-DM Study NCT06593327NA3 sites๐Ÿ“ Dallas๐Ÿ“ Dallas๐Ÿ“ Dallas University of Texas Southwestern Medical Center ยท Tests: Intensive Prevention Strategy
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy